• GW 6471 (SKU B7797): Reliable PPARα Antagonism in Metabolic

  2026-06-24

  This article addresses the practical challenges faced by biomedical researchers studying PPARα-mediated processes, focusing on the application of GW 6471 (SKU B7797) as a robust PPARα antagonist. Scenario-driven Q&A blocks provide evidence-based guidance on experimental design, protocol optimization, and data interpretation, emphasizing the reproducibility and scientific value of GW 6471 from APExBIO.

• TSPAN18 Drives Prostate Cancer Bone Metastasis via STIM1 Sta

  2026-06-23

  Zhou et al. (2023) reveal that TSPAN18 promotes bone metastasis in prostate cancer by protecting STIM1 from TRIM32-mediated ubiquitination, enhancing calcium influx and cell invasiveness. This mechanistic insight highlights TSPAN18 as a potential therapeutic target and provides a foundation for further research into hormone and calcium signaling in metastatic prostate cancer.

• Nirmatrelvir (PF-07321332): Precision Tool for SARS-CoV-2 3C

  2026-06-23

  Explore the distinctive mechanism and advanced research applications of Nirmatrelvir (PF-07321332) as a selective SARS-CoV-2 3CL protease inhibitor. Discover how new assay strategies and mechanistic insight set this oral antiviral apart for antiviral therapeutics research.

• H-89 in Osteogenic Metabolism: Decoding PKA’s Role in cAMP P

  2026-06-22

  Explore how H-89, a potent cAMP-dependent protein kinase inhibitor, uniquely empowers researchers to unravel metabolic and signaling mechanisms in osteoblast biology. This article provides a novel, integrative perspective on cAMP pathway modulation, rooted in recent advances on Wnt-induced O-GlcNAcylation and bone formation.

• Mechanisms of DON-Induced Liver Injury: Mitophagy and Nrf2 S

  2026-06-22

  This study reveals that deoxynivalenol (DON), a widespread foodborne mycotoxin, induces liver injury by overactivating PINK1/Parkin-mediated mitophagy and suppressing the cytoprotective p62-Keap1-Nrf2 pathway. These findings clarify the molecular sequence underlying DON hepatotoxicity and inform the design of targeted experimental models for liver injury research.

• Phosphoproteomic Adaptation to Chronic Cabozantinib in RCC C

  2026-06-21

  This study delineates how renal cell carcinoma (RCC) cells adapt their phosphoproteomic landscape and motility under acute versus chronic Cabozantinib (XL184) exposure. By integrating quantitative phosphoproteomics with functional motility assays, the work reveals timescale-dependent signaling reprogramming, highlighting sustained MET inhibition and selective activation of adhesion- and MAPK-linked pathways in chronic drug adaptation.

• BMAL1 Phase Separation Enables Circadian Transcriptional Hub

  2026-06-20

  This study reveals that BMAL1, a core circadian clock protein, undergoes phase separation to form dynamic nuclear condensates acting as transcriptional hubs. The phosphorylation state of BMAL1's intrinsically disordered region is a key regulator of this process, offering new insight into the molecular timing of circadian rhythms and providing a framework for targeted investigation of protein phosphorylation dynamics.

• Perospirone (SM-9018 Free Base): Applied Neuropsychiatric an

  2026-06-19

  Perospirone (SM-9018 free base) uniquely bridges neuropsychiatric and cardiovascular research by combining potent serotonin-dopamine receptor modulation with direct vascular Kv1.5 channel inhibition. This article delivers actionable workflows and troubleshooting insights, empowering scientists to optimize schizophrenia and vascular function models using APExBIO’s high-quality reagent.

• Patient-Derived Gastric Cancer Assembloids: Modeling Tumor-S

  2026-06-19

  The reference study introduces a robust patient-derived gastric cancer assembloid model that integrates matched tumor organoids and stromal cell subpopulations, enabling more physiologically relevant drug testing and biomarker analysis. This approach reveals the critical influence of the tumor microenvironment on drug response, supporting the development of personalized therapeutic strategies.

• Thiazovivin: Practical Parameters for ROCK Inhibitor Use

  2026-06-18

  Thiazovivin is a small molecule ROCK inhibitor that addresses cell survival bottlenecks during workflows such as induced pluripotent stem cell (iPSC) generation and human embryonic stem cell (hESC) passaging. It is specifically suited to research contexts requiring enhanced reprogramming efficiency and post-trypsinization survival but is not appropriate for diagnostic or clinical use.

• Diuron-Induced Acute Renal Injury via JAK2/STAT1 Pathway

  2026-06-18

  This study integrates network toxicology, transcriptomics, and cell-based assays to reveal that Diuron (3-(3,4-dichlorophenyl)-1,1-dimethylurea) induces acute kidney injury by activating the JAK2/STAT1 signaling pathway. These mechanistic insights advance risk assessment and guide future research on the nephrotoxicity of environmental herbicides.

• Demethyleneberberine in Translational Cell Models: Protocols

  2026-06-17

  Demethyleneberberine (DMB) empowers translational research by integrating anti-inflammatory, neuroprotective, and anti-cancer actions into robust, pathway-specific workflows. Discover how to leverage its multi-target activity for reproducible results in NSCLC, autoimmune hepatitis, and neurodegeneration models—plus troubleshooting strategies for optimal assay performance.

• Phalloidin (B7678): Technical Guidance for F-Actin Stabiliza

  2026-06-17

  Phalloidin (SKU B7678) is a cyclic heptapeptide toxin designed for high-affinity binding and stabilization of filamentous actin (F-actin), enabling robust cytoskeleton visualization in fixed and permeabilized samples. It is not suitable for live-cell imaging or applications requiring reversible actin binding. This reagent is best used when static preservation of actin architecture is essential for microscopy-based cell biology research.

• AZD6482: Precision PI3Kβ Inhibition for Disease Modeling

  2026-06-16

  Explore AZD6482, a highly selective PI3Kβ inhibitor, and its advanced role in dissecting disease mechanisms and metabolic pathways. This article offers deep scientific insights and unique assay guidance for researchers seeking to optimize PI3Kβ-targeted studies.

• Apicidin Disrupts Oocyte Quality via Meiotic and Epigenetic

  2026-06-16

  This study demonstrates that Apicidin, an emerging mycotoxin and potent histone deacetylase inhibitor, significantly impairs mammalian oocyte maturation by disrupting the meiotic spindle apparatus and modulating histone acetylation. The findings highlight mechanistic links between environmental epigenetic disruptors and reproductive toxicity, offering new insights for toxicology research and HDAC inhibitor applications.

458 records 14/31 page Previous Next First page 上5页 1112131415 下5页 Last page